Barbara Geladakis is an experienced medical doctor and strong healthcare services professional with a history of working in the hospital & health care industry.

In 2018 she founded Rodi Fertility, an R&D company based in NY through which she runs extensive clinical studies and research projects and 2022 started its commercial operations in Europe.

Her research is focused on reproductive immunology and other autoimmune diseases. She has been granted an international patent and is developing a portfolio of international patents on solutions to key autoimmune diseases and valuable future applications.

She is a member of the European Society for Reproductive Immunology, the Hellenic Society of Immunology and member of the task force of Y-Immunologist of Europe and a speaker at multiple international & national scientific conferences.

In 2019 she received a scientific award at the Panhellenic Congress of Autoimmune Diseases, Rheumatology and Clinical Immunology for the effectiveness and efficacy one of Rodi’s patented formulas and in 2020 Rodi Pharmaceuticals won the 7th annual ENVOLVE Award, one of the most prestigious entrepreneurship awards for start-up companies in Greece.

She speaks fluently five languages.